Momenta Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Momenta Pharmaceuticals Inc.

MNTA 52.48

0.0%

Oct 2 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tom pope who wrote (2497)	9/16/2010 11:04:49 AM
From: Biomaven	Read Replies (1) of 3027

The real question is how much you trust the public statements of the TEVA's CEO: We are confident that we are very close to getting the approval for our generic version of deep vein thrombosis treatment Lovenox after providing all the answers requested by the FDA. If you take his statement at face value, it's hard to argue that MNTA is underpriced here. My gut tells me that its unlikely that Teva came up with the miracle sauce prior to the FDA's 5-part test, and so they will have to rework their application. That belief of mine implies he's just talking his book here, but who knows. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next